21122420

Source:http://linkedlifedata.com/resource/pubmed/id/21122420

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0087111, umls-concept:C0205225, umls-concept:C1514474, umls-concept:C1516119, umls-concept:C1519810, umls-concept:C2239176, umls-concept:C2348767
pubmed:issue	8
pubmed:dateCreated	2010-12-2
pubmed:abstractText	To evaluate the efficacy and analyze the prognostic factors of sorafenib treatment in patient with unresectable primary hepatocellular carcinoma (HCC).
pubmed:language	chi
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7910681
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzenesulfonates, http://linkedlifedata.com/resource/pubmed/chemical/Pyridines, http://linkedlifedata.com/resource/pubmed/chemical/sorafenib
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0253-3766
pubmed:author	pubmed-author:FengZ LZL, pubmed-author:GanYu-hongYH, pubmed-author:GeNin-lingNL, pubmed-author:RenZheng-gangZG, pubmed-author:WangYan-hongYH, pubmed-author:XieXiao-yingXY, pubmed-author:YeSheng-longSL, pubmed-author:ZhangBo-hengBH, pubmed-author:ZhangLanL
pubmed:issnType	Print
pubmed:volume	32
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	630-3
pubmed:meshHeading	pubmed-meshheading:21122420-Adult, pubmed-meshheading:21122420-Aged, pubmed-meshheading:21122420-Alopecia, pubmed-meshheading:21122420-Antineoplastic Agents, pubmed-meshheading:21122420-Benzenesulfonates, pubmed-meshheading:21122420-Carcinoma, Hepatocellular, pubmed-meshheading:21122420-Chemoembolization, Therapeutic, pubmed-meshheading:21122420-Diarrhea, pubmed-meshheading:21122420-Disease Progression, pubmed-meshheading:21122420-Follow-Up Studies, pubmed-meshheading:21122420-Humans, pubmed-meshheading:21122420-Hypertension, pubmed-meshheading:21122420-Liver Neoplasms, pubmed-meshheading:21122420-Male, pubmed-meshheading:21122420-Middle Aged, pubmed-meshheading:21122420-Neoplasm Staging, pubmed-meshheading:21122420-Pyridines, pubmed-meshheading:21122420-Skin Diseases, pubmed-meshheading:21122420-Survival Rate
pubmed:year	2010
pubmed:articleTitle	[Therapeutic efficacy and prognostic factors of sorafenib treatment in patients with unresectable primary hepatocellular carcinoma].
pubmed:affiliation	Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
pubmed:publicationType	Journal Article, English Abstract, Evaluation Studies